PRL3-zumab as an anti-angiogenic therapy in neovascular eye diseases
K
Koon Hwee Ang
M
Min Thura
Q
Queenie Shu Woon Tan
A
Abhishek Gupta
K
Kam Yew Kuan
J
Jie Li
P
Pei Ling Chia
B
Beiying Qiu
J
Jimmy Ming Hong
K
Ke Guo
X
Xiaomeng Wang
X
Xinyi Su
Q
Qi Zeng
Article Details
Journal
Nature Communications
Volume / Issue
Vol. 16, Issue 1
Published
May 23, 2025
ISSN
2041-1723
Publisher
Nature Portfolio
Authors (13)
K
Koon Hwee Ang
M
Min Thura
Q
Queenie Shu Woon Tan
A
Abhishek Gupta
K
Kam Yew Kuan
J
Jie Li
P
Pei Ling Chia
B
Beiying Qiu
J
Jimmy Ming Hong
K
Ke Guo
X
Xiaomeng Wang
X
Xinyi Su
Q
Qi Zeng
Related Articles from this Journal
Synthesis of adaptive 15N-nitrosyl-Co7 nanocluster for electrocatalytic C–H functionalization
Chao Wu, Xu Zhang et al.
Aug 2026
10.1038/s41467-026-76516-1
Pan-Ebolavirus nanoparticle vaccine provides protection in rodents from lethal infection by Zaire and Sudan viruses
Connor Weidle, Natalie Brunette et al.
Aug 2026
10.1038/s41467-026-76114-1
Multi-population GWAS meta-analysis identifies bladder cancer susceptibility loci and highlights genetic regulation of smoking-related risk
Ludmila Prokunina-Olsson, Oscar Florez-Vargas et al.
Aug 2026
10.1038/s41467-026-76157-4
Genome-wide annotation of human multi-nucleotide variants reveals widespread functional differences from single nucleotide variants
Weiwei Jin, Wen Cao et al.
Aug 2026
10.1038/s41467-026-76470-y
Allele-specific chromatin architecture shapes imprinted domains and coordinates a distal enhancer and antisense transcription at the mouse Mest-Copg2 domain
Bongmin Bae, Katherine Gu et al.
Aug 2026
10.1038/s41467-026-76506-3